Qigu capsule alleviates dexamethasone-induced muscle dysfunction through mitochondrial biogenesis.

QGC ameliorates dexamethasone-induced skeletal muscle dysfunction by activating AMPK/ PGC-1α, which might be developed as a therapeutic agent for treating age-related muscle weakness.

Authors

Institutions

Publication Details

Journal
PubMed
Published
2025-08-01
DOI
https://doi.org/10.19852/j.cnki.jtcm.2025.04.004
Primary Topic
Healthcare and Venom Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Qigu capsule alleviates dexamethasone-induced muscle dysfunction through mitochondrial biogenesis.

Hongsheng Zhan, G E Haiya, Shi Jinyu, Yang Zongrui
PubMed
Healthcare and Venom Research
article

Qigu capsule alleviates dexamethasone-induced muscle dysfunction through mitochondrial biogenesis.

Hongsheng Zhan, G E Haiya, Shi Jinyu, Yang Zongrui
article en

Abstract

QGC ameliorates dexamethasone-induced skeletal muscle dysfunction by activating AMPK/ PGC-1α, which might be developed as a therapeutic agent for treating age-related muscle weakness.

PubMedVol. 45(4)
Shanghai University of Traditional Chinese Medicine (CN), Shuguang Hospital (CN)
Openalex Percentile: Top 77%
Healthcare and Venom Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Qigu capsule alleviates dexamethasone-induced muscle dysfunction through mitochondrial biogenesis. — Hongsheng Zhan, G E Haiya, et al. · PubMed (2025) | TGRS Research Map | TGRS